Lou A. Smets

3.6k total citations
97 papers, 2.9k citations indexed

About

Lou A. Smets is a scholar working on Molecular Biology, Neurology and Cancer Research. According to data from OpenAlex, Lou A. Smets has authored 97 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 19 papers in Neurology and 17 papers in Cancer Research. Recurrent topics in Lou A. Smets's work include Neuroblastoma Research and Treatments (18 papers), Glycosylation and Glycoproteins Research (13 papers) and Acute Lymphoblastic Leukemia research (13 papers). Lou A. Smets is often cited by papers focused on Neuroblastoma Research and Treatments (18 papers), Glycosylation and Glycoproteins Research (13 papers) and Acute Lymphoblastic Leukemia research (13 papers). Lou A. Smets collaborates with scholars based in Netherlands, Italy and Belgium. Lou A. Smets's co-authors include Wim P. Van Beek, P. Emmelot, C. Loesberg, A van der Does-van den Berg, Elisabeth R. van Wering, A. Veerman, C. H. Van Zantwijk, Gertjan J.L. Kaspers, Rob Pieters and Marja Rutgers and has published in prestigious journals such as Nature, The EMBO Journal and Blood.

In The Last Decade

Lou A. Smets

97 papers receiving 2.8k citations

Peers

Countries citing papers authored by Lou A. Smets

Since Specialization

Citations

This map shows the geographic impact of Lou A. Smets's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lou A. Smets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lou A. Smets more than expected).

Fields of papers citing papers by Lou A. Smets

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lou A. Smets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lou A. Smets. The network helps show where Lou A. Smets may publish in the future.

Co-authorship network of co-authors of Lou A. Smets

This figure shows the co-authorship network connecting the top 25 collaborators of Lou A. Smets. A scholar is included among the top collaborators of Lou A. Smets based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lou A. Smets. Lou A. Smets is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Human megakaryocytes cultured in vitro accumulate serotonin but not meta-iodobenzylguanidine whereas platelets concentrate both 2002 ·Experimental Hematology ·Godelieve A.M. Tytgat, (unknown), P.A. Voûte, Lou A. Smets, Marja Rutgers	8
2	A comparison of targetting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients 2001 ·European Journal of Nuclear Medicine and Molecular Imaging ·Cornelis A. Hoefnagel, Marja Rutgers, (unknown), Lou A. Smets, (unknown), Marina L. Meli, (unknown), Hanspeter Amstutz, P. August Schubiger, Ilse Novak‐Hofer	40
3	Targeting of meta-iodobenzylguanidine to SK-N-SH human neuroblastoma xenografts: Tissue distribution, metabolism and therapeutic efficacy 2000 ·International Journal of Cancer ·Marja Rutgers, (unknown), C.A. Hoefnagel, P.A. Voûte, Lou A. Smets	21
4	Signalling steps in apoptosis by ether lipids 1999 ·APOPTOSIS ·Lou A. Smets, (unknown), G. S. Salomons	18
5	Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG) 1999 ·British Journal of Cancer ·(unknown), (unknown), Martine L.M. Lamfers, (unknown), Marion Essers, Jos H. Beijnen, Lou A. Smets	41
6	Bioavailability and toxicity after oral administration of m-iodobenzylguanidine (MIBG) 1999 ·British Journal of Cancer ·(unknown), Marja Rutgers, Martin A. van der Valk, Jos H. Beijnen, Lou A. Smets	5
7	Mutational analysis ofBax andBcl-2 in childhood acute lymphoblastic leukaemia 1998 ·International Journal of Cancer ·Gajja S. Salomons, (unknown), (unknown), Manon Verwijs-Janssen, H. Behrendt, József Zsíros, Lou A. Smets	12
8	Chemical characterization and comparative cellular effects of meta-iodobenzyl guanidine and benzyl guanidine 1997 ·Cancer Chemotherapy and Pharmacology ·(unknown), Lou A. Smets, Marja Rutgers, (unknown), Roel H. Fokkens, (unknown), (unknown)	7
9	Bcl-2 expression and glucocorticoid-induced apoptosis of leukemic and lymphoma cells 1996 ·Leukemia & lymphoma ·Lou A. Smets, (unknown)	27
10	Agonist-free transformation of the glucocorticoid receptor in human B-lymphoma cells 1996 ·The Journal of Steroid Biochemistry and Molecular Biology ·(unknown), Lou A. Smets, (unknown)	4
11	DNA index and %S‐phase cells determined in acute lymphoblastic leukemia of children: A report from studies ALL V, ALL VI, and ALL VII (1979–1991) of the dutch childhood leukemia study group and the Netherlands workgroup on cancer genetics and cytogenetics 1995 ·Medical and Pediatric Oncology ·Lou A. Smets, Rosalyn Slater, Elisabeth R. van Wering, A van der Does-van den Berg, A. A. M. Hart, A. Veerman, W. A. Kamps	24
12	High levels of non-activated receptors in glucocorticoid-sensitive S49wt mouse lymphoma cells incubated with dexamethasone 1994 ·The Journal of Steroid Biochemistry and Molecular Biology ·(unknown), Lou A. Smets, (unknown), (unknown), (unknown)	3
13	Temperature dependence of glucocorticoid binding in sensitive and refractory murine leukaemia cells 1993 ·Leukemia Research ·(unknown), Lou A. Smets, (unknown), (unknown), (unknown)	6
14	Pharmacokinetics and intracellular distribution of the tumor‐targeted radiopharmaceutical m‐iodo‐benzylguanidine in SK‐N‐SH neuroblastoma and PC‐12 pheochromocytoma cells 1991 ·International Journal of Cancer ·Lou A. Smets, (unknown), Marja Rutgers, (unknown), (unknown)	36
15	Mitochondrial effects of the guanidino group-containing cytostatic drugs, m-iodobenzylguanidine and methylglyoxal bis (guanylhydrazone) 1991 ·Biochemical Pharmacology ·C. Loesberg, (unknown), Johannes C. Romijn, Lou A. Smets	18
16	Measurement of von Willebrand Factor Antigen in Plasma and Platelets with an Enzyme-Linked Immunosorbent Assay Based on Two Murine Monoclonal Antibodies 1991 ·Pathophysiology of Haemostasis and Thrombosis ·István Tornai, Paul Declerck, Lou A. Smets, Jef Arnout, Hans Deckmyn, (unknown), Jos Vermylen	18
17	Early blindness and coma during intrathecal chemotherapy for meningeal carcinomatosis 1990 ·Cancer ·Willem Boogerd, (unknown), Lou A. Smets	30
18	Meta-iodobenzylguanidine (MIBG), a novel high-affinity substrate for cholera toxin that interferes with cellular mono(ADP-ribosylation) 1990 ·Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·C. Loesberg, (unknown), Lou A. Smets	42
19	Extragranular storage of the neuron blocking agent meta-iodobenzylguanidine (MIBG) in human neuroblastoma cells 1990 ·Biochemical Pharmacology ·Lou A. Smets, (unknown), (unknown), C. Loesberg	37
20	Mitogenic and antimitogenic effects of cholera toxin‐mediated cyclic AMP levels in 3T3 cells 1987 ·Journal of Cellular Physiology ·Lou A. Smets, (unknown)	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact